Susceptibility to Plasmodium yoelii preerythrocytic infection in BALB/c substrains is determined at the point of hepatocyte invasion

Infection and Immunity

Volumn 83, Issue 1, 2015, Pages 39-47

  Kaushansky, Alexis ^a   Austin, Laura S ^a,b   Mikolajczak, Sebastian A ^a   Lo, Fang Y ^a   Miller, Jessica L ^a   Douglass, Alyse N ^a   Arang, Nadia ^a   Vaughan, Ashley M ^a   Gardner, Malcolm J ^a,b   Kappe, Stefan H I ^a,b  

^a SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOST FACTOR; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INVASION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEPATITIS; INFECTION SENSITIVITY; LIVER CELL; MOUSE; NONHUMAN; PLASMODIUM YOELII; PLASMODIUM YOELII INFECTION; PLASMODIUM YOELII PREERYTHROCYTIC INFECTION; POLYPLOIDY; SPOROZOITE; ANIMAL; BAGG ALBINO MOUSE; DISEASE PREDISPOSITION; ENDOCYTOSIS; GENE EXPRESSION PROFILING; IMMUNOLOGY; MALARIA; PARASITOLOGY; PHYSIOLOGY;

ANIMALS; DISEASE SUSCEPTIBILITY; ENDOCYTOSIS; FEMALE; GENE EXPRESSION PROFILING; HEPATOCYTES; MALARIA; MICE, INBRED BALB C; PLASMODIUM YOELII;

EID: 84919464220     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.02230-14     Document Type: Article

References (44)

1. Lindner SE, Miller JL, Kappe SH. 2012. Malaria parasite pre-erythrocytic infection: preparation meets opportunity. Cell Microbiol 14:316-324. http://dx.doi.org/10.1111/j.1462-5822.2011.01734.x.
2. Wright GJ, Rayner JC. 2014. Plasmodium falciparum erythrocyte invasion: combining function with immune evasion. PLoS Pathog 10: e1003943. http://dx.doi.org/10.1371/journal.ppat.1003943.
3. Bartholdson SJ, Crosnier C, Bustamante LY, Rayner JC, Wright GJ. 2013. Identifying novel Plasmodium falciparum erythrocyte invasion receptors using systematic extracellular protein interaction screens. Cell Microbiol 15:1304-1312. http://dx.doi.org/10.1111/cmi.12151.
4. Cowman AF, Berry D, Baum J. 2012. The cellular and molecular basis for malaria parasite invasion of the human red blood cell. J Cell Biol 198:961-971. http://dx.doi.org/10.1083/jcb.201206112.
5. Zimmerman PA, Ferreira MU, Howes RE, Mercereau-Puijalon O. 2013. Red blood cell polymorphism and susceptibility to Plasmodium vivax. Adv Parasitol 81:27-76. http://dx.doi.org/10.1016/B978-0-12-407826-0.00002-3.
6. Miller LH, Mason SJ, Clyde DF, McGinniss MH. 1976. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med 295:302-304.
7. Scheller LF, Wirtz RA, Azad AF. 1994. Susceptibility of different strains of mice to hepatic infection with Plasmodium berghei. Infect Immun 62:4844-4847.
8. Khan ZM, Vanderberg JP. 1991. Role of host cellular response in differential susceptibility of nonimmunized BALB/c mice to Plasmodium berghei and Plasmodium yoelii sporozoites. Infect Immun 59:2529-2534.
9. March S, Ng S, Velmurugan S, Galstian A, Shan J, Logan DJ, Carpenter AE, Thomas D, Sim BK, Mota MM, Hoffman SL, Bhatia SN. 2013. A microscale human liver platform that supports the hepatic stages of Plasmodium falciparum and vivax. Cell Host Microbe 14:104-115. http://dx.doi.org/10.1016/j.chom.2013.06.005.
10. Silvie O, Rubinstein E, Franetich JF, Prenant M, Belnoue E, Renia L, Hannoun L, Eling W, Levy S, Boucheix C, Mazier D. 2003. Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity. Nat Med 9:93-96. http://dx.doi.org/10.1038/nm808.
11. Yalaoui S, Huby T, Franetich JF, Gego A, Rametti A, Moreau M, Collet X, Siau A, van Gemert GJ, Sauerwein RW, Luty AJ, Vaillant JC, Hannoun L, Chapman J, Mazier D, Froissard P. 2008. Scavenger receptor BI boosts hepatocyte permissiveness to Plasmodium infection. Cell Host Microbe 4:283-292. http://dx.doi.org/10.1016/j.chom.2008.07.013.
12. Rodrigues CD, Hannus M, Prudencio M, Martin C, Goncalves LA, Portugal S, Epiphanio S, Akinc A, Hadwiger P, Jahn-Hofmann K, Rohl I, van Gemert GJ, Franetich JF, Luty AJ, Sauerwein R, Mazier D, Koteliansky V, Vornlocher HP, Echeverri CJ, Mota MM. 2008. Host scavenger receptor SR-BI plays a dual role in the establishment of malaria parasite liver infection. Cell Host Microbe 4:271-282. http://dx.doi.org/10.1016/j.chom.2008.07.012.
13. Coppi A, Tewari R, Bishop JR, Bennett BL, Lawrence R, Esko JD, Billker O, Sinnis P. 2007. Heparan sulfate proteoglycans provide a signal to Plasmodium sporozoites to stop migrating and productively invade host cells. Cell Host Microbe 2:316-327. http://dx.doi.org/10.1016/j.chom.2007.10.002.
14. Frevert U, Sinnis P, Cerami C, Shreffler W, Takacs B, Nussenzweig V. 1993. Malaria circumsporozoite protein binds to heparan sulfate proteoglycans associated with the surface membrane of hepatocytes. J Exp Med 177:1287-1298. http://dx.doi.org/10.1084/jem.177.5.1287.
15. Potter M. 1985. History of the BALB/c family. Curr Top Microbiol Immunol 122:1-5.
16. Jin Y, Kebaier C, Vanderberg J. 2007. Direct microscopic quantification of dynamics of Plasmodium berghei sporozoite transmission from mosquitoes to mice. Infect Immun 75:5532-5539. http://dx.doi.org/10.1128/IAI.00600-07.
17. Miller JL, Murray S, Vaughan AM, Harupa A, Sack B, Baldwin M, Crispe IN, Kappe SH. 2013. Quantitative bioluminescent imaging of pre-erythrocytic malaria parasite infection using luciferase-expressing Plasmodium yoelii. PLoS One 8:e60820. http://dx.doi.org/10.1371/journal.pone.0060820.
18. Vaughan AM, Mikolajczak SA, Wilson EM, Grompe M, Kaushansky A, Camargo N, Bial J, Ploss A, Kappe SH. 2012. Complete Plasmodium falciparum liver-stage development in liver-chimeric mice. J Clin Invest 122:3618-3628. http://dx.doi.org/10.1172/JCI62684.
19. Kaushansky A, Ye AS, Austin LS, Mikolajczak SA, Vaughan AM, Camargo N, Metzger PG, Douglass AN, MacBeath G, Kappe SH. 2013. Suppression of host p53 is critical for Plasmodium liver-stage infection. Cell Rep 3:630-637. http://dx.doi.org/10.1016/j.celrep.2013.02.010.
20. Austin LS, Kaushansky A, Kappe SH. 2014. Susceptibility to Plasmodium liver stage infection is altered by hepatocyte polyploidy. Cell Microbiol 16:784-795. http://dx.doi.org/10.1111/cmi.12282.
21. Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL. 2013. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol 14:R36. http://dx.doi.org/10.1186/gb-2013-14-4-r36.
22. Trapnell C, Hendrickson DG, Sauvageau M, Goff L, Rinn JL, Pachter L. 2013. Differential analysis of gene regulation at transcript resolution with RNA-seq. Nat Biotechnol 31:46-53. http://dx.doi.org/10.1038/nbt.2450.
23. Tavares J, Formaglio P, Thiberge S, Mordelet E, Van Rooijen N, Medvinsky A, Menard R, Amino R. 2013. Role of host cell traversal by the malaria sporozoite during liver infection. J Exp Med 210:905-915. http://dx.doi.org/10.1084/jem.20121130.
24. Mota MM, Pradel G, Vanderberg JP, Hafalla JC, Frevert U, Nussenzweig RS, Nussenzweig V, Rodriguez A. 2001. Migration of Plasmodium sporozoites through cells before infection. Science 291:141-144. http://dx.doi.org/10.1126/science.291.5501.141.
25. Vanderberg JP, Frevert U. 2004. Intravital microscopy demonstrating antibody-mediated immobilisation of Plasmodium berghei sporozoites injected into skin by mosquitoes. Int J Parasitol 34:991-996. http://dx.doi.org/10.1016/j.ijpara.2004.05.005.
26. Sack BK, Miller JL, Vaughan AM, Douglass A, Kaushansky A, Mikolajczak S, Coppi A, Gonzalez-Aseguinolaza G, Tsuji M, Zavala F, Sinnis P, Kappe SH. 2014. Model for in vivo assessment of humoral protection against malaria sporozoite challenge by passive transfer of monoclonal antibodies and immune serum. Infect Immun 82:808-817. http://dx.doi.org/10.1128/IAI.01249-13.
27. Baer K, Roosevelt M, Clarkson AB, Jr van Rooijen N, Schnieder T, Frevert U. 2007. Kupffer cells are obligatory for Plasmodium yoelii sporozoite infection of the liver. Cell Microbiol 9:397-412. http://dx.doi.org/10.1111/j.1462-5822.2006.00798.x.
28. Pradel G, Frevert U. 2001. Malaria sporozoites actively enter and pass through rat Kupffer cells prior to hepatocyte invasion. Hepatology 33: 1154-1165. http://dx.doi.org/10.1053/jhep.2001.24237.
29. Liehl P, Zuzarte-Luis V, Chan J, Zillinger T, Baptista F, Carapau D, Konert M, Hanson KK, Carret C, Lassnig C, Muller M, Kalinke U, Saeed M, Chora AF, Golenbock DT, Strobl B, Prudencio M, Coelho LP, Kappe SH, Superti-Furga G, Pichlmair A, Vigario AM, Rice CM, Fitzgerald KA, Barchet W, Mota MM. 2014. Host-cell sensors for Plasmodium activate innate immunity against liver-stage infection. Nat Med 20:47-53. http://dx.doi.org/10.1038/nm.3424.
30. Miller JL, Sack BK, Baldwin M, Vaughan AM, Kappe SH. 2014. Interferon-mediated innate immune responses against malaria parasite liver stages. Cell Rep 7:436-447. http://dx.doi.org/10.1016/j.celrep.2014.03.018.
31. Teuscher C, Hickey WF, Grafer CM, Tung KS. 1998. A common immunoregulatory locus controls susceptibility to actively induced experimental allergic encephalomyelitis and experimental allergic orchitis in BALB/c mice. J Immunol 160:2751-2756.
32. Seetharamaiah GS, Land KJ. 2006. Differential susceptibility of BALB/c and BALB/cBy mice to Graves' hyperthyroidism. Thyroid 16:651-658. http://dx.doi.org/10.1089/thy.2006.16.651.
33. Gonçalves LA, Almeida P, Mota MM, Penha-Goncalves C. 2008. Malaria liver stage susceptibility locus identified on mouse chromosome 17 by congenic mapping. PLoS One 3:e1874. http://dx.doi.org/10.1371/journal.pone.0001874.
34. Gonçalves LA, Rodrigues-Duarte L, Rodo J, Vieira de Moraes L, Marques I, Penha-Goncalves C. 2013. TREM2 governs Kupffer cell activation and explains belr1 genetic resistance to malaria liver stage infection. Proc Natl Acad Sci U S A 110:19531-19536. http://dx.doi.org/10.1073/pnas.1306873110.
35. Briones MR, Tsuji M, Nussenzweig V. 1996. The large difference in infectivity for mice of Plasmodium berghei and Plasmodium yoelii sporozoites cannot be correlated with their ability to enter into hepatocytes. Mol Biochem Parasitol 77:7-17. http://dx.doi.org/10.1016/0166-6851(96)02574-1.
36. Morikawa K, Zhao Z, Date T, Miyamoto M, Murayama A, Akazawa D, Tanabe J, Sone S, Wakita T. 2007. The roles of CD81 and glycosaminoglycans in the adsorption and uptake of infectious HCV particles. J Med Virol 79:714-723. http://dx.doi.org/10.1002/jmv.20842.
37. Scarselli E, Ansuini H, Cerino R, Roccasecca RM, Acali S, Filocamo G, Traboni C, Nicosia A, Cortese R, Vitelli A. 2002. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J 21:5017-5025. http://dx.doi.org/10.1093/emboj/cdf529.
38. Barth H, Schafer C, Adah MI, Zhang F, Linhardt RJ, Toyoda H, Kinoshita-Toyoda A, Toida T, Van Kuppevelt TH, Depla E, Von Weizsacker F, Blum HE, Baumert TF. 2003. Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate. J Biol Chem 278:41003-41012. http://dx.doi.org/10.1074/jbc.M302267200.
39. Prudêncio M, Rodrigues CD, Hannus M, Martin C, Real E, Goncalves LA, Carret C, Dorkin R, Rohl I, Jahn-Hoffmann K, Luty AJ, Sauerwein R, Echeverri CJ, Mota MM. 2008. Kinome-wide RNAi screen implicates at least 5 host hepatocyte kinases in Plasmodium sporozoite infection. PLoS Pathog 4:e1000201. http://dx.doi.org/10.1371/journal.ppat.1000201.
40. Lupberger J, Zeisel MB, Xiao F, Thumann C, Fofana I, Zona L, Davis C, Mee CJ, Turek M, Gorke S, Royer C, Fischer B, Zahid MN, Lavillette D, Fresquet J, Cosset FL, Rothenberg SM, Pietschmann T, Patel AH, Pessaux P, Doffoel M, Raffelsberger W, Poch O, McKeating JA, Brino L, Baumert TF. 2011. EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy. Nat Med 17:589-595. http://dx.doi.org/10.1038/nm.2341.
41. Lindner SE, Swearingen KE, Harupa A, Vaughan AM, Sinnis P, Moritz RL, Kappe SH. 2013. Total and putative surface proteomics of malaria parasite salivary gland sporozoites. Mol Cell Proteomics 12:1127-1143. http://dx.doi.org/10.1074/mcp.M112.024505.
42. Dobson SE, Augustijn KD, Brannigan JA, Schnick C, Janse CJ, Dodson EJ, Waters AP, Wilkinson AJ. 2009. The crystal structures of macrophage migration inhibitory factor from Plasmodium falciparum and Plasmodium berghei. Protein Sci 18:2578-2591. http://dx.doi.org/10.1002/pro.263.
43. Miller JL, Harupa A, Kappe SH, Mikolajczak SA. 2012. Plasmodium yoelii macrophage migration inhibitory factor is necessary for efficient liver-stage development. Infect Immun 80:1399-1407. http://dx.doi.org/10.1128/IAI.05861-11.
44. Kaushansky A, Kappe SH. 2011. The crucial role of hepatocyte growth factor receptor during liver-stage infection is not conserved among Plasmodium species. Nat Med 17:1180-1181. (Author reply, 17:1181.) http://dx.doi.org/10.1038/nm.2456.